CAS: 60569-19-9; (1-Methyl-4-Piperidyl) 2,2-Diphenyl-2-Propoxy-Acetate
该化合物是一种合成化合物,主要用作抗淋巴剂,主要用于治疗过活的膀胱和尿尿失禁,其作用是抑制膀胱肌肉受体的乙酰胆碱酯酶作用,从而减少非自愿收缩,增加膀胱容量.Propiverine的特征是其化学结构,包括管状环和芳香味,有助于其药理特性.该物质一般是口服的,以其相对有利的副作用特征而著称,与其他抗胆碱性药物相比,其药理学作用包括吸收,新陈代谢和排泄,中度半衰期允许每天服用一至两次.此外,丙丙烯可能表现出某种程度的...
- 英文名称(1-Methyl-4-Piperidyl) 2,2-Diphenyl-2-Propoxy-Acetate
- 中文名称丙哌维林
- 其它别名(1-Methyl-4-piperidyl) 2,2-diphenyl-2-propoxy-acetate
- CAS编号60569-19-9
- MFCD编号:MFCD00865259
- FDA UNII编号:468GE2241L
- 分子式:C23H29NO3分子量:367.48
- 产品CID: 1582716
- 产品分类有机原料 → 苯类化合物 → 苯和取代衍生物
物理性质
MSDS等安全信息
上下游产品
CAS号54556-98-8 盐酸丙哌维林 | CAS号3608-67-1 羟基-二苯基-乙酸 1-甲基-...合成工艺路线路线简述
📜盐酸丙哌维林置于sodium Carbonate体系中,用 水 作为反应溶剂,化学反应生成 丙哌维林
参考文献: Anticholinergic Neuroprotective Composition And Methods[fr] Composition Et Procédés Neuroprotecteurs Anticholinergiques
标题: Anticholinergic Neuroprotective Composition And Methods[fr] Composition Et Procédés Neuroprotecteurs Anticholinergiques
摘要:本发明涉及一种包含丙烯胺,托斯匹铵或格隆溴铵的药物组合物;以及一种非抗胆碱能的抗恶心药物.它还涉及一种包含高剂量索利那非或其药用盐的药物组合物;以及一种非抗胆碱能的抗恶心药物.还描述了含有高剂量nspacha的药物组合物,用于增加achei血浓度并对抗神经退行性疾病.该发明还涉及一种诱导神经保护和对抗神经退行性疾病的方法,适用于患有阿尔茨海默型痴呆症的患者,以及一种用于增加接受achei剂量治疗的人体受试者的乙酰胆碱酯酶抑制剂(achei)血液水平的方法.
海关参考信息
- 2902600000-乙苯
2905122000-异丙醇
2905310000-1,2-乙二醇
2906210000-苄醇 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:EP-4630405-A1
优先权日:2022-12-06
标题 :Process for the synthesis of substituted tetrahydrofuran modulators of sodium channels
专利号:WO-2024123815-A1
优先权日:2022-12-06
标 题:Process for the synthesis of substituted tetrahydrofuran modulators of sodium channels
专利号:US-2023271983-A1
优先权日:2020-07-29
标题 :Functionalized isonitriles and products, preparation and uses thereof
发明人：SOTELO PÉREZ EDDY; AZUAJE GUERRERO JHONNY ALBERTO; MAJELLARO MARIA
权利人:UNIV SANTIAGO COMPOSTELA
摘要:The present invention relates to functionalized isonitrile compounds, formed by means of multicomponent environmentally friendly reactions, suitable for coupling to functional molecules such as biomolecules, APIs, chromophore and fluorophore molecules. The invention also relates to conjugates between said isonitrile compounds and functional molecules, which are useful in the synthesis of pharmaceutic drugs or tools, fluorescent molecules and labels, polymeric smart materials. The invention furthermore provides a kit for the in-vitro preparation of the functionalized isontrile compounds and conjugates. The invention also contemplates the medical use of said compounds and conjugates.
专利号:JP-2012530050-A
优先权日:2010-03-15
标题:Synthesis of propiverine hydrochloride
专利号:WO-2011114195-A1
优先权日:2010-03-15
标题:Synthesis of propiverine hydrochloride
专利号:EP-2470504-B1
优先权日:2010-03-15
标题:Synthesis of propiverine hydrochloride
发明人：ANDAGAR RAMAKRISHNA RAMESHA; ROY ANJAN KUMAR
权利人:ANDAGAR RAMAKRISHNA RAMESHA; ROY ANJAN KUMAR
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
参考文献:10.1007/s11255-011-0030-y
摘要:Lehnert T, Weisser M, Till H, Rolle U. The effects of long-term medical treatment combined with clean intermittent catheterization in children with neurogenic detrusor overactivity. International Urology and Nephrology. 2011 Jul 21;44(2):335–41. doi: 10.1007/s11255-011-0030-y.
📝 需求与反馈
尽可能描述清楚需求与问题信息
